Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 4

MedEdTalks - Ophthalmology

Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 3

Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 2

This educational podcast will review the use of combination therapy, new drug formulations, and procedures to improve outcomes for patients with ocular surface disease.

Enhancing Outcomes in OSD Using Combination Therapy and New Drug Formulations, With Drs. Lisa Nijm and John Sheppard

In this educational podcast, experts discuss emerging therapies for their ability to improve outcomes in patients with ocular surface disease. Faculty also review the safety and efficacy data to support new and emerging treatment options for OSD.

Differentiating New Strategies for Treating OSD: A Look at the Evidence With Drs. Lisa Nijm and Eric Donnenfeld

This educational podcast will review important considerations for the diagnosis and management of ocular surface disease (OSD) in special patient populations. Faculty will provide pearls for preventing and managing OSD in individuals at elevated risk, including those undergoing ocular surgery, those with glaucoma or diabetes, as well as individuals on medications known to disrupt the ocular surface. 

Managing Ocular Surface Disease in Special Patient Populations With Drs. Lisa Nijm and Vance Thompson

Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions, Volume, 10, Issue 1

In this podcast, expert clinicians will discuss best practices regarding the use of Port Delivery System with ranibizumab.

Port Delivery System With Ranibizumab, With Nancy M. Holekamp, MD, and Arshad M. Khanani, MD, MA

In this podcast, expert clinicians will discuss achieving vascular stability through inhibition of Ang-2. To obtain CME credit, go here: https://tinyurl.com/y58538ef 

Achieving Vascular Stability through Inhibition of Ang-2 in AMD and DME, With Nancy M. Holekamp, MD, and Carl D. Regillo, MD, FACS

In this podcast, expert clinicians will discuss emerging gene therapies for AMD and DME.   To obtain CME credit, go here: https://tinyurl.com/yusxpn44 

Emerging Delivery Systems in Neovascular Retinal Disease: Focus on Gene Therapy, With Nancy M. Holekamp, MD, and Arshad M. Khanani, MD, MA

In this podcast, expert clinicians will discuss emerging delivery system devices in neovascular retinal disease.   To obtain CME credit, please go here: https://tinyurl.com/thma9fwp

Emerging Delivery Systems in Neovascular Retinal Disease: Focus on Devices, With Nancy M. Holekamp, MD, and Carl D. Regillo, MD, FACS

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and David Eichenbaum discuss how advances in the treatment of RVO achieved in clinical trials can be applied to real-world practice.

Curbside Consults on Retinal Vein Occlusion Management: Deciphering New Data on RVO Treatment – How Do they Affect Real-World Practice?

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and Christina Weng assess the effect of treating RVO early in its course for the improvement of visual outcomes.

Curbside Consults on Retinal Vein Occlusion Management: Treating RVO Early to Improve Outcomes

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and David Eichenbaum examine innovations in imaging that can improve the monitoring of treatment response in patients with RVO.

Curbside Consults on Retinal Vein Occlusion Management: Use of Imaging in Monitoring Treatment Response in RVO

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and Christina Weng discuss the current use of imaging and biomarkers in the diagnosis as well as prognosis of RVO.

Curbside Consults on Retinal Vein Occlusion Management: Use of Imaging in the Diagnosis of RVO

MedEdTalks Ophthalmology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on ophthalmology topics, such as nAMD and Diabetic Retinopathy and includes interviews with Dr. Rishi Singh from the Cole Eye Institute, Dr. Andrew Moshfeghi from the USC Roski Eye Institute, Dr. Dilsher Dhoot from California Retina Consultants, Dr. Theodore Leng from Byers Eye Institute at Stanford, Dr. Nathan Steinle from California Retina Consultants, Dr. Nancy Holekamp from Washington University School of Medicine and Dr. Arshad Khanani from University of Nevada.

hubhopper

MedEdTalks - Ophthalmology

hubhopper